Myriad Genetics Inc (MYGN)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	-88,000	-257,400	-123,700	-48,700	-194,800
Total assets	US$ in thousands	1,027,600	1,146,500	1,198,700	1,320,700	1,418,800
Operating ROA		-8.56%	-22.45%	-10.32%	-3.69%	-13.73%

December 31, 2024 calculation

Operating ROA = Operating income ÷ Total assets
= $-88,000K ÷ $1,027,600K
= -8.56%

The operating return on assets (ROA) for Myriad Genetics Inc has shown fluctuations over the years based on the provided data. In 2020, the operating ROA was notably low at -13.73%, indicating that the company's operating income generated from its assets was insufficient to cover its asset base.

By the end of 2021, the operating ROA improved to -3.69%, although still negative, showing a slight recovery in the company's ability to generate operating income from its assets. However, in 2022, there was a decline in the operating ROA to -10.32%, suggesting that Myriad Genetics struggled to effectively utilize its assets to generate operating profits.

The operating ROA continued to deteriorate significantly by the end of 2023, reaching -22.45%, indicating a substantial decrease in the company's profitability relative to its asset base. This substantial drop may raise concerns about the company's operational efficiency and financial performance during that period.

In 2024, there was a slight improvement in the operating ROA to -8.56%, reflecting a partial recovery in utilizing its assets to generate operating income. Overall, the negative trend in the operating ROA figures over the years indicates challenges in Myriad Genetics Inc's ability to efficiently generate operating profits relative to its asset investments.